Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility

Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists N-Acylthiadiazolines, a New Class of Liver X Receptor Agonists with Selectivity for LXRβ Carboxylic acid based quinolines as liver X receptor modulators that have LXRβ receptor binding selectivity Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator Discovery of a 2-hydroxyacetophenone derivative as an outstanding linker to enhance potency and β-selectivity of liver X receptor agonist Liver X receptor agonists with selectivity for LXRβ; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRβ and low blood–brain penetration 4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists